Brown, gray, or dark patches on the white of the eye usually come from melanin deposited either in or on top of the sclera, the tough outer coat that gives the “white” its color. The causes range from completely harmless freckle-like spots that many people are born with, to drug side effects, metabolic disorders, and, in uncommon cases, growths that need medical attention. Because the sclera is normally so pale, even a small amount of pigment stands out, which is why a new brown spot can look alarming even when it turns out to be nothing serious.
Conjunctival Nevi and Other Harmless Spots
The most common reason for a brown patch on the white of the eye is a conjunctival nevus, essentially a mole on the thin, clear membrane that covers the sclera. These spots are collections of pigment-producing cells (melanocytes) sitting in the conjunctiva, and they behave a lot like the freckles and moles you see on skin. They often appear in childhood or adolescence, can darken or lighten with sun exposure or hormonal changes such as puberty or pregnancy, and the vast majority never become dangerous. A study examining genetic markers in conjunctival nevi found that roughly two-thirds carried the same BRAF V600E mutation seen in common skin moles, reinforcing how biologically similar these eye “freckles” are to ordinary skin moles.1PubMed. BRAF Mutation Status in Inflamed Juvenile Conjunctival Nevus, Primary Acquired Melanosis and Conjunctival Common Nevus
A conjunctival nevus is typically flat or slightly raised, well-defined, and may contain small cysts visible under magnification. The color can be light tan, chocolate brown, or even dark enough to look nearly black. If you’ve had a stable brown spot on the white of your eye since you were a teenager, odds are strong that it’s a nevus. That said, any change in size, color, shape, or the appearance of new blood vessels feeding into the spot warrants an eye exam, because on rare occasions a nevus can transform into melanoma.2PubMed. Conversion of Conjunctival Nevus to Melanoma in a Patient Taking the TYK2 Inhibitor Deucravacitinib
Nevus of Ota and Deep Scleral Pigmentation
Some people are born with a broader pattern of brown, blue-gray, or slate-colored pigmentation that affects not just the eye but also the skin around it, typically on one side of the face. This condition, called oculodermal melanocytosis or nevus of Ota, results from melanocytes that settled into the deeper layers of the sclera, the skin of the eyelid, and nearby structures during fetal development. Because the pigment sits deep beneath the surface, it often looks blue-gray rather than the warm brown of a superficial nevus.3PubMed Central. An update on ophthalmological perspectives in oculodermal melanocytosis (Nevus of Ota)
Nevus of Ota is more common in people of East Asian and African descent, and it’s usually present at birth or appears during puberty. The condition itself is painless and doesn’t affect vision. However, it does carry a long-term elevated risk of glaucoma and, less commonly, uveal melanoma (a cancer inside the eye rather than on its surface).3PubMed Central. An update on ophthalmological perspectives in oculodermal melanocytosis (Nevus of Ota) For that reason, people with nevus of Ota benefit from periodic dilated eye exams even if the pigmentation has looked the same for years.
Primary Acquired Melanosis
When brown pigmentation appears on the white of the eye for the first time in an adult who didn’t have it before, and it’s flat rather than raised, one possibility is primary acquired melanosis (PAM). PAM shows up as a patchy, irregular, flat brown discoloration on the conjunctiva. It looks a bit like a diffuse tan stain rather than a distinct freckle, and it tends to develop in middle-aged or older adults, particularly those with fair skin.
What makes PAM clinically important is that some forms can progress to conjunctival melanoma, while others remain entirely benign. The distinction hinges on what the cells look like under a microscope. In a large study of 311 eyes with PAM, none of the cases without atypical cells progressed to melanoma, and none of the cases with only mild atypia did either. Among cases with severe atypia, about 13% eventually developed into melanoma.4PubMed Central. Primary acquired melanosis of the conjunctiva: experience with 311 eyes That means PAM is not a death sentence by any stretch, but it does need to be biopsied and monitored so the cells can be examined. Your ophthalmologist can’t determine the level of atypia just by looking.
Interestingly, genetic analysis has shown that the BRAF V600E mutation found frequently in benign conjunctival nevi is rare in PAM, appearing in under 5% of cases.1PubMed. BRAF Mutation Status in Inflamed Juvenile Conjunctival Nevus, Primary Acquired Melanosis and Conjunctival Common Nevus This genetic difference suggests PAM follows a different biological pathway from ordinary nevi, which partly explains why PAM has a higher potential to turn malignant even though it starts out looking like simple pigmentation.
Drug-Induced Scleral Discoloration
Certain medications can deposit pigment directly into the sclera, conjunctiva, or both, producing a color change that catches people completely off guard. The most well-known offender is minocycline, a tetracycline-class antibiotic prescribed for acne, rosacea, and other chronic skin conditions. Long-term use can lead to a distinctive blue-gray or brownish discoloration of the sclera, often most visible near the inner and outer edges of the eye where the horizontal eye muscles attach to the globe.5PubMed Central. Minocycline-Induced Ocular Ochronosis Patients may also notice darkening of the gums, nail beds, and skin at the same time.
Of all the tetracycline antibiotics, minocycline is by far the most likely to cause this kind of pigmentation. Doxycycline, a close relative that’s often used for similar conditions, very rarely does the same.6Clinical Insights in Eyecare. Conjunctival and Macular Hyperpigmentation Associated with Tetracyclines: Case Reports and Review of Literature The exact mechanism behind the pigment deposition isn’t fully settled, though it likely involves drug-protein complexes binding to collagen-rich tissues, and possibly oxidation products of the drug itself accumulating in connective tissue over time.7PubMed. Minocycline-Induced Scleral and Dermal Hyperpigmentation Once the drug is stopped, some of the pigmentation may slowly fade, but it doesn’t always reverse completely, especially after years of use.
Silver compounds are another cause worth knowing about, though rarer in practice. Chronic exposure to colloidal silver supplements, silver-containing eye drops (used historically for infections), or occupational silver dust can cause a condition called argyria, where silver particles deposit in the skin, conjunctiva, and other tissues. The resulting discoloration is typically a slate-gray or blue-gray rather than true brown, and it’s permanent.8PubMed Central. Clinical and Forensic Aspects of the Different Subtypes of Argyria
Metabolic Disorders That Discolor the Eye
A rare but striking cause of scleral darkening is ochronosis, a hallmark of the inherited metabolic disorder alkaptonuria. In this condition, the body can’t fully break down certain amino acids, leading to a buildup of homogentisic acid. Over decades, this compound polymerizes and deposits as a dark pigment in connective tissues throughout the body, including cartilage, tendons, heart valves, and the sclera.9PubMed Central. On the ocular findings in ochronosis: a systematic review of literature In the eyes, the pigment usually appears as brown or black spots on the sclera, and it may also affect the ear cartilage (which darkens visibly), the tendons in the hands, and eventually the joints.
People with alkaptonuria often don’t notice eye changes until middle age, because the pigment accumulates slowly. By that point, the discoloration is typically accompanied by arthritis in the spine and large joints, dark urine (if they ever happen to notice), and darkened ear cartilage. It’s a condition that most people and even many doctors haven’t heard of, but it’s one of the oldest known metabolic diseases. The scleral spots themselves are harmless to vision, though the systemic effects of the disorder on joints and heart valves can be significant.
Minocycline use can also produce a form of ocular ochronosis that mimics the appearance of the inherited disease without the underlying metabolic problem.5PubMed Central. Minocycline-Induced Ocular Ochronosis Clinically, the two can look almost identical, so a medication history is essential for distinguishing them.
Senile Scleral Plaques
In older adults, you sometimes see well-defined gray or brownish-gray patches on the sclera, typically located just in front of where the horizontal eye muscles attach. These are senile scleral plaques, a degenerative change in the sclera itself rather than a pigment deposit on its surface. They result from the breakdown of collagen and elastin in the scleral tissue, combined with deposition of calcium and lipids.10Ophthalmology in Russia. Ultrasound Biomicroscopy Eye Anterior Segment in the Diagnosis of Senile Scleral Plaques. Clinical Case
These plaques are harmless and don’t affect vision or eye health. They’re essentially the scleral equivalent of age spots on skin. However, because they occur in a similar location to certain melanotic lesions and can look dark against the white background, they occasionally prompt concern. An ophthalmologist can usually diagnose them on appearance and location alone, sometimes confirmed with ultrasound imaging if there’s any doubt.
Normal Anatomical Variants That Mimic Pigmentation
Not every dark spot on the sclera involves pigment at all. Axenfeld loops, for example, are normal anatomical structures, small loops of the long posterior ciliary nerves that poke through the sclera and become visible as dark spots on the surface. They can look like embedded foreign bodies or pigmented lesions, but they’re completely benign and present from birth.11Anales de PediatrÃa (English Edition). Axenfeld loop: Differential diagnosis of intraocular foreign body These are most often noticed incidentally during an eye exam and don’t require any treatment.
Racial melanosis is another common and entirely normal variant. Many people, particularly those with darker skin tones, have flat, brownish pigmentation on the conjunctiva that’s been present since childhood. This is simply a higher concentration of melanin in the conjunctival tissue, analogous to having darker skin elsewhere on the body. It doesn’t carry any increased cancer risk and doesn’t require monitoring beyond what any routine eye exam provides.
How Ophthalmologists Tell These Apart
Given how many different things can cause brown or dark patches on the eye’s surface, the diagnostic process matters. Most of the time, an ophthalmologist can narrow down the likely cause with a slit-lamp examination, the standard magnified view of the eye’s front structures, combined with patient history. Key questions include when the discoloration first appeared, whether it has changed, what medications you’ve been taking, whether you have a family history of metabolic diseases, and whether the discoloration affects one eye or both.
For lesions that could be PAM, a nevus showing changes, or anything that looks potentially malignant, biopsy remains the gold standard. Newer imaging tools, particularly high-resolution optical coherence tomography (OCT), are increasingly useful for evaluating surface lesions without cutting. In one study comparing OCT findings with biopsy results, the imaging correctly characterized the depth and type of involvement for a majority of lesions and helped flag cases where the clinical impression turned out to be wrong. Clinical suspicion and final biopsy diagnosis disagreed in about a third of cases, and OCT pointed toward the correct diagnosis in most of those discrepancies.12PubMed Central. Differential diagnostic importance of swept-source optical coherence tomography in ocular surface lesions That one-in-three mismatch between clinical impression and pathology underscores why biopsy is still necessary for any lesion that’s genuinely suspicious.
When to See a Doctor
A brown spot on the white of your eye that has been stable for years and was present since childhood is almost certainly harmless. The situations that warrant a prompt evaluation are fairly specific:
- New pigmentation in adulthood: A flat brown patch that appears for the first time after age 30 or 40 should be examined, since PAM typically develops in this age range and its significance can only be determined by biopsy.
- A changing lesion: Any existing spot that grows, darkens, develops irregular borders, or sprouts new blood vessels needs evaluation. Changes can be slow and hard to notice, so photographic documentation during routine exams helps.
- Discoloration in both eyes with medication use: If you’ve been on minocycline or another tetracycline for months or years and notice darkening of the sclera (or gums, nails, or skin), mention it to both your prescribing doctor and an ophthalmologist.
- Gray or brown patches with joint pain: The combination of scleral discoloration and progressive arthritis, especially in the spine, could point to alkaptonuria and warrants metabolic workup.
Photographic monitoring has become a simple and valuable tool. Many ophthalmologists now photograph pigmented lesions at each visit so that subtle changes are easier to detect over time. If you notice a spot on your eye, snapping a well-lit photo yourself and keeping it for comparison at your next appointment is a reasonable step.
Why Human Eyes Are White in the First Place
A useful piece of context for understanding scleral discoloration is why the human sclera is so conspicuously white to begin with. Most primates have darker scleras, often brown or muted, which effectively camouflages where their eyes are pointed. Humans are a striking exception, and recent research suggests this has social roots. A study across 108 primate species found that scleral brightness was strongly linked to cooperative social behavior: species with brighter, more visible scleras tended to be more prosocial and socially tolerant, while species with higher rates of lethal aggression toward their own kind tended to have darker scleras.13PubMed Central. The evolutionary drivers of primate scleral coloration
The idea is that a bright white sclera makes gaze direction highly visible to others, which is useful in species that rely on coordinating attention, sharing information about threats, and cooperating on tasks. In species where revealing your gaze direction could be a disadvantage, such as those with high rates of within-group violence, a darker sclera acts as camouflage. More recent work has added nuance to this picture, showing that darker primate eyes can actually be more effective for communicating gaze direction in dim, close-range conditions, while lighter eyes work better at longer range in bright light.14PubMed Central. Gaze in context: non-human eyes can be more salient under ecologically relevant conditions The human sclera’s whiteness, in other words, may be optimized for the kind of communication we do most: reading intentions at a distance, in daylit open environments.
This evolutionary backdrop helps explain why even a small patch of brown on the sclera catches your eye so effectively. Your brain is wired to pay exquisite attention to the sclera because it provides social information. A spot of discoloration disrupts that signal, which is why you notice it at all and why it can feel disproportionately alarming compared to, say, a freckle on your arm.